Evaluating radiation treatment outcomes for uterine cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study collects data on the radiation treatment of uterine neoplasms, including endometrial and cervical cancers. It aims to evaluate tumor response and potential toxicity associated with different dosages, fractionation, and techniques used in radiotherapy. By analyzing a large sample of patients treated since 2000, the study seeks to identify correlations between treatment characteristics and radiation-induced toxicities, ultimately aiming to personalize treatment and improve patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Female patients, aged ≥ 18 years, with a new or previous diagnosis of malignant uterine neoplasm, starting from 01/01/2000, treated at the Radiotherapy Unit of the Sant'Orsola Polyclinic
* Obtaining informed consent

Exclusion Criteria:

* Patients with a new or previous diagnosis of malignant uterine neoplasm who choose not to undergo radiation treatment at the Radiotherapy Unit of the Sant'Orsola Polyclinic

Where it's running

• IRCCS Azienda Ospedaliero - Universitaria di Bologna
  Bologna, Italy Recruiting

Study contacts

• Principal investigator: Alessio Giuseppe Morganti, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
• Study coordinator: Alessio Giuseppe Morganti, MD
• Email: alessio.morganti2@unibo.it
• Phone: +39 0516363136

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Oral Progestin Tablets With Radiotherapy vs. Standard Radiotherapy and Chemotherapy in High-Risk NSMP Endometrial Cancer

  This trial tests whether adding oral progestin tablets after radiotherapy is as effective as the standard radiotherapy plus chemotherapy for high-risk NSMP endometrial cancer, hoping to reduce side effects and improve quality of life.

  Recruiting at 12 sites Phase 3 University College, London · Bath and 11 other locations · NCT07831902

• AI into Ultrasound Diagnostics in Reproductive Medicine

  Researchers are testing AI tools that analyze transvaginal ultrasound images to help detect endometriosis, adenomyosis, uterine masses, and pregnancy-related receptivity in women aged 18-45.

  Recruiting Semmelweis University · Budapest, Budapest · NCT07810920

• Ultrasound changes in fibroids during relugolix‑estradiol‑norethisterone treatment.

  This project will see if relugolix‑estradiol‑norethisterone changes the ultrasound appearance of fibroids in premenopausal women with heavy menstrual bleeding.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma · NCT06953076

• Examining the effects of brachytherapy on gynecological cancers

  This study looks at how well brachytherapy works for women aged 18 to 80 with different types of gynecological cancers.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT05242861

• Using reminders and self-sampling to boost cervical cancer screening participation

  This study is testing if sending text reminders and using self-sampling kits can help women at high risk for cervical cancer get screened more often.

  Recruiting at 6 sites Karolinska Institutet · Luleå, Norrbotten County and 5 other locations · NCT04061967

• Optimizing treatment models for uterine cancers

  This study is testing new ways to create personalized treatment plans for patients with uterine cancer who are having surgery to see if it can improve their outcomes.

  Recruiting University Hospital Tuebingen · Tübingen · NCT03624712

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.